Aroa Biosurgery Ltd - Asset Resilience Ratio

Latest as of September 2025: 12.13%

Aroa Biosurgery Ltd (ARX) has an Asset Resilience Ratio of 12.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Aroa Biosurgery Ltd (ARX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$11.56 Million
≈ $8.18 Million USD Cash + Short-term Investments

Total Assets

AU$95.27 Million
≈ $67.41 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Aroa Biosurgery Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Aroa Biosurgery Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Aroa Biosurgery Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Aroa Biosurgery Ltd (ARX) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$11.56 Million 12.13%
Total Liquid Assets AU$11.56 Million 12.13%

Asset Resilience Insights

  • Moderate Liquidity: Aroa Biosurgery Ltd has 12.13% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Aroa Biosurgery Ltd Industry Peers by Asset Resilience Ratio

Compare Aroa Biosurgery Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for Aroa Biosurgery Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Aroa Biosurgery Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 13.00% AU$12.87 Million
≈ $9.10 Million
AU$98.94 Million
≈ $70.01 Million
-3.84pp
2024-03-31 16.84% AU$17.16 Million
≈ $12.14 Million
AU$101.88 Million
≈ $72.09 Million
-14.39pp
2023-03-31 31.23% AU$34.07 Million
≈ $24.10 Million
AU$109.07 Million
≈ $77.17 Million
-14.25pp
2022-03-31 45.48% AU$47.62 Million
≈ $33.70 Million
AU$104.71 Million
≈ $74.09 Million
+43.50pp
2021-03-31 1.99% AU$1.45 Million
≈ $1.03 Million
AU$73.12 Million
≈ $51.74 Million
+0.84pp
2020-03-31 1.14% AU$944.72K
≈ $668.45K
AU$82.54 Million
≈ $58.40 Million
+1.12pp
2019-03-31 0.03% AU$9.60K
≈ $6.79K
AU$37.96 Million
≈ $26.86 Million
-0.23pp
2018-03-31 0.26% AU$37.00K
≈ $26.18K
AU$14.30 Million
≈ $10.12 Million
-0.31pp
2017-03-31 0.57% AU$37.00K
≈ $26.18K
AU$6.52 Million
≈ $4.61 Million
+0.02pp
2016-03-31 0.55% AU$35.00K
≈ $24.76K
AU$6.36 Million
≈ $4.50 Million
+0.08pp
2015-03-31 0.47% AU$35.00K
≈ $24.76K
AU$7.51 Million
≈ $5.31 Million
+0.05pp
2014-03-31 0.42% AU$35.00K
≈ $24.76K
AU$8.41 Million
≈ $5.95 Million
+0.04pp
2013-03-31 0.37% AU$35.00K
≈ $24.76K
AU$9.36 Million
≈ $6.62 Million
+0.05pp
2012-03-31 0.32% AU$35.00K
≈ $24.76K
AU$10.93 Million
≈ $7.73 Million
-0.11pp
2011-03-31 0.43% AU$35.00K
≈ $24.76K
AU$8.07 Million
≈ $5.71 Million
-0.25pp
2010-03-31 0.68% AU$35.00K
≈ $24.76K
AU$5.13 Million
≈ $3.63 Million
+0.64pp
2009-03-31 0.04% AU$35.00K
≈ $24.76K
AU$83.08 Million
≈ $58.79 Million
-0.01pp
2008-03-31 0.05% AU$35.00K
≈ $24.76K
AU$71.60 Million
≈ $50.66 Million
-5.03pp
2007-03-31 5.08% AU$4.50 Million
≈ $3.18 Million
AU$88.53 Million
≈ $62.64 Million
-7.98pp
2005-03-31 13.06% AU$2.56 Million
≈ $1.81 Million
AU$19.60 Million
≈ $13.87 Million
-18.74pp
2004-03-31 31.80% AU$4.91 Million
≈ $3.47 Million
AU$15.44 Million
≈ $10.93 Million
-6.39pp
2003-03-31 38.19% AU$4.63 Million
≈ $3.28 Million
AU$12.12 Million
≈ $8.58 Million
-17.87pp
2002-03-31 56.06% AU$6.93 Million
≈ $4.90 Million
AU$12.37 Million
≈ $8.75 Million
+50.57pp
2001-03-31 5.49% AU$760.00K
≈ $537.75K
AU$13.85 Million
≈ $9.80 Million
--
pp = percentage points

About Aroa Biosurgery Ltd

AU:ARX Australia Medical Devices
Market Cap
$130.04 Million
AU$183.78 Million AUD
Market Cap Rank
#18281 Global
#561 in Australia
Share Price
AU$0.53
Change (1 day)
+0.00%
52-Week Range
AU$0.51 - AU$0.80
All Time High
AU$1.54
About

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more